The GLP-1 drug market has surged dramatically in the past four years, driven by soaring demand for weight-loss treatments that also tackle related conditions like diabetes and heart disease. Valued at ...
Pfizer has now filed a suit in federal court, following its claim in state court on Friday. It is riding Trump-era political ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback